ALL vs BIIB · P/E 4.9, rev $18.60B vs P/E 21, rev $9.89B
The Allstate Corporation (ALL) versus Biogen Inc (BIIB) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Latest reported ALL revenue for 2026-06-30 was $18.60B. Net income was $3.27B. Revenue was up 9.8% from 2026-03-31 to 2026-06-30. ALL currently screens at market cap $56.89B and trailing P/E 4.9.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Not investment advice. Open the ALL and BIIB stock pages for the full models.
Not investment advice.